P35968 (VGFR2_HUMAN) Homo sapiens (Human)

Vascular endothelial growth factor receptor 2 UniProtKBInterProSTRINGInteractive Modelling

1356 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

54 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of VEGFR-2 domains 4-5 in complex with DARPin D4b
5oyj
 Heteromer
326-549
7×NAG; 3×GLC; 4×CA; 1×NA; 1×CAC; 1×ACT;
Assess
CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2 IN A TETRAGONAL CRYSTAL FORM
2x1x
 Heteromer
P49767; 		122-326
4×NAG; 4×NAG; 2×HG; 2×NAG;
Assess
Crystal Structure of VEGF-C in Complex with Domains 2 and 3 of VEGFR2
2x1w
 Heteromer
P49767; 		124-326
5×NAG; 2×NAG; 1×CS; 2×NAG;
Assess
VEGFR-2/VEGF-A COMPLEX STRUCTURE
3v2a
 Heteromer
P15692; 		132-329
Assess
VEGFR-2/VEGF-E complex structure
3v6b
 Heteromer
P52584; 		132-329
Assess
Structural basis for the function of two anti-VEGF receptor antibodies
3s35
 Heteromer
220-330
1×NAG; 6×CA; 1×NAG;
Assess
Structural basis for the function of two anti-VEGF receptor antibodies
3s36
 Heteromer
220-330
Assess
Structural basis for the function of two anti-VEGF receptor antibodies
3s37
 Heteromer
220-329
Assess
NMR spatial structure of the trimeric mutant TM domain of VEGFR2 receptor.
2met
homo-3-mer759-795
Assess
Crystal structure of VEGFR2 extracellular domain D7
3kvq
homo-2-mer667-756
Assess
Spatial structure of dimeric VEGFR2 membrane domain in DPC micelles
2m59
homo-2-mer759-795
Assess
NMR spatial structure of mutant dimeric TM domain of VEGFR2 receptor
2meu
homo-2-mer759-795
Assess
CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736)…
4agc
monomer801-1169
1×AXI;
Assess
CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) …
4agd
monomer802-1169
1×B49;
Assess
CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951)
4ase
monomer807-1169
1×AV9;
Assess
Crystal Structure of VEGFR2 (Juxtamembrane and Kinase Domains) in Complex with SORAFENIB (BAY 43-90…
4asd
monomer807-1168
1×BAX;
Assess
Crystal structure of human VEGFR2 kinase domain with a novel pyrrolopyrimidine inhibitor.
3vhe
monomer811-1169
1×42Q;
Assess
Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 18)
6gqo
monomer811-1168
1×F82;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a pyridinyl-triazine inhibitor
2p2h
monomer815-1172
1×994;
Assess
Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative
3vo3
monomer812-1168
1×0KF; 1×EDO;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a pyridyl-pyrimidine benzimidazole in…
3ewh
monomer815-1171
1×K11; 1×EDO;
Assess
Crystal Structure of the Kinase domain of Human VEGFR2 with a [1,3]thiazolo[5,4-b]pyridine derivati…
3vnt
monomer812-1168
1×0JA; 3×EDO;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a benzamide inhibitor
3be2
monomer815-1171
1×RAJ;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a pyrazolone inhibitor
3u6j
monomer815-1171
1×03X;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibit…
2rl5
monomer815-1171
1×2RL;
Assess
Crystal structure of Vegfr2 with a benzimidazole-urea inhibitor
2oh4
monomer816-1171
2×SO4; 1×GIG;
Assess
Crystal structure of human VEGFR2 kinase domain with Compound A.
3vid
monomer813-1168
1×4TT;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a nicotinamide inhibitor
2p2i
monomer817-1172
1×608;
Assess
Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 35)
6gqq
monomer813-1167
1×F8B;
Assess
Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor
6xvj
monomer813-1167
1×O35;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a benzoxazole inhibitor
2qu6
monomer817-1171
1×SO4; 1×857;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with motesanib
3efl
monomer817-1171
1×706;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a back pocket binder
3vhk
monomer814-1168
1×BPK; 1×EDO;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor
3cp9
monomer817-1171
1×C19;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor
2qu5
monomer816-1170
1×276;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor
3b8r
monomer818-1171
1×EDO; 1×887;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor
3b8q
monomer818-1171
1×900;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a benzisoxazole inhibitor
3dtw
monomer818-1171
1×A96;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with PF- 00337210 (N,2-dimethyl-6-(7-(2-mo…
2xir
monomer816-1168
1×00J;
Assess
KDR in complex with ligand sorafenib
3wze
monomer815-1167
1×BAX; 1×ACT; 1×DTT;
Assess
CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-Methyl-2-(3-(…
4ag8
monomer816-1168
1×AXI;
Assess
Structure of VEGFR2 kinase domain in complex with BIBF1120
3c7q
monomer819-1171
5×SO4; 1×XIN;
Assess
Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine
3cjg
monomer816-1168
2×SO4; 1×KIM;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a bisamide inhibitor
3cpb
monomer819-1171
1×C92;
Assess
Vegfr2 in complex with a novel 4-amino-furo[2,3-d]pyrimidine
1ywn
monomer820-1171
1×LIF;
Assess
Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine
3cjf
monomer817-1168
4×SO4; 1×SAV;
Assess
Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor
3cpc
monomer820-1171
1×C52;
Assess
Crystal structure of VEGFR2 in complex with a 2-anilino-5-aryl-oxazole inhibitor
1y6b
monomer819-1168
1×AAX;
Assess
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
1vr2
monomer820-1168
Assess
KDR in complex with ligand lenvatinib
3wzd
monomer820-1167
1×LEV; 4×DTT; 4×EDO; 1×GOL; 1×SO4;
Assess
Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor bearing an …
6xvk
monomer821-1168
1×O3E;
Assess
Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 23)
6gqp
monomer821-1168
1×F88;
Assess
Crystal structure of VEGFR2 in complex with a 2-anilino-5-aryl-oxazole inhibitor
1y6a
monomer820-1167
1×AAZ;
Assess
Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Kinase Domain in complex with AAL993
5ew3
monomer821-1168
1×5T2;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5oyj.1.Cmonomer0.73326-549
1×GLC;100.00
Assess
3v2a.1.Amonomer0.71132-329
100.00
Assess
3vhk.1.Amonomer0.70814-1168
1×BPK;100.00
Assess
3gqi.1.Amonomer0.57820-1174
55.81
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26fwx.1.Amonomer0.57231-419
17.71
Assess
Isoform 25t89.1.Dmonomer0.5731-660
34.80
Assess
Isoform 28tb7.1.Bmonomer0.50552-650
15.36
Assess
Isoform 35t89.1.Dmonomer0.5731-660
34.80
Assess